Shopping Cart 0
Cart Subtotal
AED 0

Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 23117

Details

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level. In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porters Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness. The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient markets manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions. The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others. The report segments the global active pharmaceutical ingredient market as Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis Biotech API Synthetic Chemical API HPAPI Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis Contract Manufacturing In-House API Manufacturing Active Pharmaceutical Ingredient Market: Type of API Segment Analysis Synthetic API Biological API Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis Branded Drugs Generic Drugs OTC Drugs Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis Cardiology Oncology Anti-Inflammatory Gastrointestinal Other

READ MORE

Table Of Content

Scope

Chapter 1. Preface 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Active pharmaceutical ingredient Market, 2015-2021, (USD Billion) 2.2. Active pharmaceutical ingredient: Market snapshot Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis 3.1. Active pharmaceutical ingredient: Market dynamics 3.2. Market Drivers 3.2.1. Increasing prevalence of chronic diseases 3.2.2. Technological advancements in the API 3.2.3. Patent expiration of major drugs that increased generic drug sales 3.2.4. Government initiatives 3.3. Restraints 3.3.1. Stringent regulatory requirement 3.3.2. Decline in global economics 3.4. Opportunity 3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment 3.5. Porters Five Forces Analysis 3.6. Market Attractiveness Analysis 3.6.1. Market attractiveness analysis by API synthesis segment 3.6.2. Market attractiveness analysis by type of manufacturing segment 3.6.3. Market attractiveness analysis by type of API segment 3.6.4. Market attractiveness analysis by drug type segment 3.6.5. Market attractiveness analysis by Application segment 3.6.6. Market attractiveness analysis by region segment Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape 4.1. Company Market Share Analysis 4.1.1. Global active pharmaceutical ingredient market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion 4.3. Price Trend Analysis 4.4. Product Portfolio 4.5. Patent Analysis (2011-2016) 4.5.1. Patent Trend 4.5.2. Patent Share by company 4.5.3. By Region Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview 5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021 5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015-2021(USD Billion) 5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015-2021 (USD Billion) 5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015-2021 (USD Billion) Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview 6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021 6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015-2021(USD Billion) 6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015-2021 (USD Billion) Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview 7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021 7.2. Global active pharmaceutical ingredient market for synthetic API, 2015-2021(USD Billion) 7.3. Global active pharmaceutical ingredient market for biological API, 2015-2021 (USD Billion) Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview 8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021 8.2. Global active pharmaceutical ingredient market for branded drugs, 2015-2021(USD Billion) 8.3. Global active pharmaceutical ingredient market for generic drugs, 2015-2021 (USD Billion) 8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015-2021 (USD Billion) Chapter 9. Global active pharmaceutical ingredient Market: Application Overview 9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021 9.2. Global active pharmaceutical ingredient market for cardiology, 2015-2021(USD Billion) 9.3. Global active pharmaceutical ingredient market for oncology, 2015-2021 (USD Billion) 9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015-2021 (USD Billion) 9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015-2021 (USD Billion) 9.6. Global active pharmaceutical ingredient market for others, 2015-2021 (USD Billion) Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis 10.1. Global active pharmaceutical ingredient market: Regional overview 10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021 10.2. North America 10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 2021 (USD Billion) 10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.2.6. U.S. 10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.3. Europe 10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 2021 (USD Billion) 10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 2021 (USD Billion) 10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 2021 (USD Billion) 10.3.6. UK 10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.3.7. France 10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 2021 (USD Billion) 10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 2021 (USD Billion) 10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 2021 (USD Billion) 10.3.8. Germany 10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion 10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion 10.4. Asia Pacific 10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 5 2021 (USD Billion) 10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 5 2021 (USD Billion) 10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 5 2021 (USD Billion) 10.4.6. China 10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.4.7. India 10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.5. Latin America 10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.5.6. Brazil 10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.6. Middle East Africa 10.6.1. Middle East Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.6.2. Middle East Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.6.3. Middle East Africa active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.6.4. Middle East Africa active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.6.5. Middle East Africa active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) Chapter 11. Company Profiles 11.1. Novartis International AG 11.1.1. Overview 11.1.2. Financials 11.1.3. Product portfolio 11.1.4. Business strategy 11.1.5. Recent developments 11.2. Pfizer 11.2.1. Overview 11.2.2. Financials 11.2.3. Product portfolio 11.2.4. Business strategy 11.2.5. Recent developments 11.3. Aurobindo 11.3.1. Overview 11.3.2. Financials 11.3.3. Product portfolio 11.3.4. Business strategy 11.3.5. Recent developments 11.4. Albemarle Corporation 11.4.1. Overview 11.4.2. Financials 11.4.3. Product portfolio 11.4.4. Business strategy 11.4.5. Recent developments 11.5. Boehringer Ingelheim 11.5.1. Overview 11.5.2. Financials 11.5.3. Product portfolio 11.5.4. Business strategy 11.5.5. Recent developments 11.6. BASF SE 11.6.1. Overview 11.6.2. Financials 11.6.3. Product portfolio 11.6.4. Business strategy 11.6.5. Recent developments Chapter 12. Patents 12.1. U.S. (US Patents) 12.2. Europe (EP documents) 12.3. Japan (Abstracts of Japan) 12.4. Global (WIPO (PCT))

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level. In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porters Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness. The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient markets manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions. The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others. The report segments the global active pharmaceutical ingredient market as Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis Biotech API Synthetic Chemical API HPAPI Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis Contract Manufacturing In-House API Manufacturing Active Pharmaceutical Ingredient Market: Type of API Segment Analysis Synthetic API Biological API Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis Branded Drugs Generic Drugs OTC Drugs Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis Cardiology Oncology Anti-Inflammatory Gastrointestinal Other

READ MORE

Scope

Chapter 1. Preface 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Active pharmaceutical ingredient Market, 2015-2021, (USD Billion) 2.2. Active pharmaceutical ingredient: Market snapshot Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis 3.1. Active pharmaceutical ingredient: Market dynamics 3.2. Market Drivers 3.2.1. Increasing prevalence of chronic diseases 3.2.2. Technological advancements in the API 3.2.3. Patent expiration of major drugs that increased generic drug sales 3.2.4. Government initiatives 3.3. Restraints 3.3.1. Stringent regulatory requirement 3.3.2. Decline in global economics 3.4. Opportunity 3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment 3.5. Porters Five Forces Analysis 3.6. Market Attractiveness Analysis 3.6.1. Market attractiveness analysis by API synthesis segment 3.6.2. Market attractiveness analysis by type of manufacturing segment 3.6.3. Market attractiveness analysis by type of API segment 3.6.4. Market attractiveness analysis by drug type segment 3.6.5. Market attractiveness analysis by Application segment 3.6.6. Market attractiveness analysis by region segment Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape 4.1. Company Market Share Analysis 4.1.1. Global active pharmaceutical ingredient market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion 4.3. Price Trend Analysis 4.4. Product Portfolio 4.5. Patent Analysis (2011-2016) 4.5.1. Patent Trend 4.5.2. Patent Share by company 4.5.3. By Region Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview 5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021 5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015-2021(USD Billion) 5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015-2021 (USD Billion) 5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015-2021 (USD Billion) Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview 6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021 6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015-2021(USD Billion) 6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015-2021 (USD Billion) Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview 7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021 7.2. Global active pharmaceutical ingredient market for synthetic API, 2015-2021(USD Billion) 7.3. Global active pharmaceutical ingredient market for biological API, 2015-2021 (USD Billion) Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview 8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021 8.2. Global active pharmaceutical ingredient market for branded drugs, 2015-2021(USD Billion) 8.3. Global active pharmaceutical ingredient market for generic drugs, 2015-2021 (USD Billion) 8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015-2021 (USD Billion) Chapter 9. Global active pharmaceutical ingredient Market: Application Overview 9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021 9.2. Global active pharmaceutical ingredient market for cardiology, 2015-2021(USD Billion) 9.3. Global active pharmaceutical ingredient market for oncology, 2015-2021 (USD Billion) 9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015-2021 (USD Billion) 9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015-2021 (USD Billion) 9.6. Global active pharmaceutical ingredient market for others, 2015-2021 (USD Billion) Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis 10.1. Global active pharmaceutical ingredient market: Regional overview 10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021 10.2. North America 10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 2021 (USD Billion) 10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.2.6. U.S. 10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.3. Europe 10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 2021 (USD Billion) 10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 2021 (USD Billion) 10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 2021 (USD Billion) 10.3.6. UK 10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.3.7. France 10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 2021 (USD Billion) 10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 2021 (USD Billion) 10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 2021 (USD Billion) 10.3.8. Germany 10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion 10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion 10.4. Asia Pacific 10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 5 2021 (USD Billion) 10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 5 2021 (USD Billion) 10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 5 2021 (USD Billion) 10.4.6. China 10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.4.7. India 10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.5. Latin America 10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.5.6. Brazil 10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) 10.6. Middle East Africa 10.6.1. Middle East Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 2021 (USD Billion) 10.6.2. Middle East Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 2021 (USD Billion) 10.6.3. Middle East Africa active pharmaceutical ingredient market revenue, by type of API, 2015 2021 (USD Billion) 10.6.4. Middle East Africa active pharmaceutical ingredient market revenue, by drug type, 2015 2021 (USD Billion) 10.6.5. Middle East Africa active pharmaceutical ingredient market revenue, by application, 2015 2021 (USD Billion) Chapter 11. Company Profiles 11.1. Novartis International AG 11.1.1. Overview 11.1.2. Financials 11.1.3. Product portfolio 11.1.4. Business strategy 11.1.5. Recent developments 11.2. Pfizer 11.2.1. Overview 11.2.2. Financials 11.2.3. Product portfolio 11.2.4. Business strategy 11.2.5. Recent developments 11.3. Aurobindo 11.3.1. Overview 11.3.2. Financials 11.3.3. Product portfolio 11.3.4. Business strategy 11.3.5. Recent developments 11.4. Albemarle Corporation 11.4.1. Overview 11.4.2. Financials 11.4.3. Product portfolio 11.4.4. Business strategy 11.4.5. Recent developments 11.5. Boehringer Ingelheim 11.5.1. Overview 11.5.2. Financials 11.5.3. Product portfolio 11.5.4. Business strategy 11.5.5. Recent developments 11.6. BASF SE 11.6.1. Overview 11.6.2. Financials 11.6.3. Product portfolio 11.6.4. Business strategy 11.6.5. Recent developments Chapter 12. Patents 12.1. U.S. (US Patents) 12.2. Europe (EP documents) 12.3. Japan (Abstracts of Japan) 12.4. Global (WIPO (PCT))

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS